Pharmaceutical Manufacturing: Is It the Antithesis of Creative Destruction?

PAT and QbD can only move forward if the industry sheds its habit of QbA (i.e., quality by analysis)

By Girish Malhotra, PE, President, EPCOT International, Inc.

Share Print Related RSS
If you are not automatically redirected, follow this link:


Share Print Reprints Permissions

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments